Companies: 10,795·Total market cap: $144.5T
Cell Source, Inc.

Cell Source, Inc.

CLCSOTCHealthcare● Active
$0.82
+$0.02(+2.50%)
Market Cap$36931360
P/E Ratio
52W High$2.25
52W Low$0.2322

Cell Source, Inc. (CLCS) Insider Trading

Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.

SEC EDGAR · FMP · CLCS · as of Jun 9, 2026

Activity summary

Buy transactions

0

P-Purchase only

Sell transactions

0

12 Months

Buy/Sell ratio

0.00

Buy/Sell (by trades)

Overall sentiment

NEUTRAL
↑ Buy 0%Active transactions only · RSU vesting excluded100% Sell ↓

Cell Source, Inc. insiders have shown mixed buying and selling activity over the past 12 Months.

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only

As of Jun 9, 2026

CLCS insider buying and selling by quarter

CLCS insider selling · CLCS insider buying stocks · quarterly insider activity

Total insider buying (incl. awards)Total insider selling
1.4M675K0
2021 Q1
2021 Q2
2021 Q3
2022 Q1

Mobile shows last 4Q · Desktop shows full 8Q

Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters

As of Jun 9, 2026

Recent insider transactions

CLCS executive sell shares · CLCS board member insider trading · CLCS insider trading SEC filing

Showing 21 most recent · Common Stock · Form 4 only

Scroll horizontally to see all columns

ZOLTY DAVID

Director

Other

Date

Jun 30

Shares

4,860

Price

$0.75

Value

$4K

View Form 4 on SEC.gov

Soave Darlene

Director

Other

Date

Jun 30

Shares

59,507

Price

$0.75

Value

$45K

View Form 4 on SEC.gov

Brown Dennis M

Director

Other

Date

Jun 30

Shares

2,976

Price

$0.75

Value

$2K

View Form 4 on SEC.gov

FRIEDMAN BENZION ABRAHAM

Director

Other

Date

Jun 30

Shares

19,440

Price

$0.75

Value

$15K

View Form 4 on SEC.gov

ZOLTY DAVID

Director

Other

Date

Dec 29

Shares

4,941

Price

$0.75

Value

$4K

View Form 4 on SEC.gov

ZOLTY DAVID

Director

Other

Date

Jun 30

Shares

4,887

Price

$0.75

Value

$4K

View Form 4 on SEC.gov

ZOLTY DAVID

Director

Other

Date

Dec 31

Shares

6,420

Price

$0.75

Value

$5K

View Form 4 on SEC.gov

ZOLTY DAVID

Director

Other

Date

Jun 26

Shares

1,339

Price

$0.75

Value

$1K

View Form 4 on SEC.gov

ZOLTY DAVID

Director

Other

Date

Dec 31

Shares

1,361

Price

$0.75

Value

$1K

View Form 4 on SEC.gov

ZOLTY DAVID

Director

Other

Date

Aug 21

Shares

1,668

Price

$0.75

Value

$1K

View Form 4 on SEC.gov

ZOLTY DAVID

Director

Other

Date

Dec 4

Shares

1,350

Price

$0.75

Value

$1K

View Form 4 on SEC.gov

FRIEDMAN BENZION ABRAHAM

Director

Other

Date

Dec 29

Shares

19,672

Price

$0.75

Value

$15K

View Form 4 on SEC.gov

FRIEDMAN BENZION ABRAHAM

Director

Other

Date

Jun 30

Shares

19,547

Price

$0.75

Value

$15K

View Form 4 on SEC.gov

FRIEDMAN BENZION ABRAHAM

Director

Other

Date

Dec 31

Shares

25,675

Price

$0.75

Value

$19K

View Form 4 on SEC.gov

FRIEDMAN BENZION ABRAHAM

Director

Other

Date

Jun 26

Shares

5,356

Price

$0.75

Value

$4K

View Form 4 on SEC.gov

FRIEDMAN BENZION ABRAHAM

Director

Other

Date

Dec 31

Shares

5,444

Price

$0.75

Value

$4K

View Form 4 on SEC.gov

FRIEDMAN BENZION ABRAHAM

Director

Other

Date

Aug 21

Shares

6,672

Price

$0.75

Value

$5K

View Form 4 on SEC.gov

FRIEDMAN BENZION ABRAHAM

Director

Other

Date

Dec 4

Shares

5,400

Price

$0.75

Value

$4K

View Form 4 on SEC.gov

Brown Dennis M

Director

Other

Date

Dec 29

Shares

3,025

Price

$0.75

Value

$2K

View Form 4 on SEC.gov

Brown Dennis M

Director

Other

Date

Jun 30

Shares

2,992

Price

$0.75

Value

$2K

View Form 4 on SEC.gov

Brown Dennis M

Director

Other

Date

Dec 31

Shares

5,934

Price

$0.75

Value

$4K

View Form 4 on SEC.gov

Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —

About CLCS insider trading

CLCS insider trades

Cell Source, Inc. (CLCS) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including CLCS. Over the past 12 months, 0 insiders have filed transactions with the SEC. CLCS insiders have been mixed buying and selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.

For Cell Source, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →

Buy/Sell signal logic
acquisitionOrDisposition field:
A = Acquisition (buy) · D = Disposition (sell)
RSU vesting (M-Exempt) excluded from sentiment
Form 4SEC filing required within 2 business days of any insider transaction
10b5-1Pre-scheduled trading plan that allows insiders to sell on autopilot
Open MktDirect purchase or sale on the open market (excludes awards, options)

Frequently asked questions

CLCS insider trading · 5 questions

The insiders of Cell Source, Inc. (CLCS) include executives and directors such as CLCS, among others. Over the past 12 months, 0 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.

CLCS board member insider tradingwho are CLCS insidersCLCS insider rosterCell Source, Inc. executives insider activity

Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026